Cell Reports Medicine,
Journal Year:
2024,
Volume and Issue:
5(4), P. 101478 - 101478
Published: April 1, 2024
Immunotherapy
has
emerged
as
a
robust
approach
against
cancer,
yet
its
efficacy
varied
among
individuals,
accompanied
by
the
occurrence
of
immune-related
adverse
events.
As
result,
immunotherapy
is
far
from
satisfactory,
and
enormous
efforts
have
been
invested
to
develop
strategies
improve
patient
outcomes.
The
gut
microbiome
now
well
acknowledged
for
critical
role
in
immunotherapy,
with
better
understanding
on
host-microbes
interaction
context
cancer
treatment.
Also,
an
increasing
number
trials
conducted
evaluate
potential
feasibility
microbiome-targeting
approaches
enhance
treatment
patients.
Here,
metabolites
(e.g.,
short-chain
fatty
acids,
tryptophan
metabolites)
underlying
mechanisms
are
explored.
application
that
aim
fecal
microbiota
transplantation,
probiotics,
dietary
intervention)
also
elaborated,
further
discussion
current
challenges
suggestions
future
research.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: May 10, 2023
Abstract
A
wide
spectrum
of
metabolites
(mainly,
the
three
major
nutrients
and
their
derivatives)
can
be
sensed
by
specific
sensors,
then
trigger
a
series
signal
transduction
pathways
affect
expression
levels
genes
in
epigenetics,
which
is
called
metabolite
sensing.
Life
body
regulates
metabolism,
immunity,
inflammation
sensing,
coordinating
pathophysiology
host
to
achieve
balance
with
external
environment.
Metabolic
reprogramming
cancers
cause
different
phenotypic
characteristics
cancer
cell
from
normal
cell,
including
proliferation,
migration,
invasion,
angiogenesis,
etc.
disorders
cells
further
create
microenvironment
many
kinds
oncometabolites
that
are
conducive
growth
cancer,
thus
forming
vicious
circle.
At
same
time,
exogenous
also
biological
behavior
tumors.
Here,
we
discuss
sensing
mechanisms
derivatives,
as
well
abnormalities
development
various
cancers,
potential
therapeutic
targets
based
on
metabolite-sensing
signaling
prevent
progression
cancer.
Cancer Discovery,
Journal Year:
2021,
Volume and Issue:
11(10), P. 2396 - 2412
Published: Aug. 16, 2021
The
cancer-immune
dialogue
subject
to
immuno-oncological
intervention
is
profoundly
influenced
by
microenvironmental
factors.
Indeed,
the
mucosal
microbiota-and
more
specifically,
intestinal
ecosystem-influences
tone
of
anticancer
immune
responses
and
clinical
benefit
immunotherapy.
Antibiotics
blunt
efficacy
checkpoint
inhibitors
(ICI),
fecal
microbial
transplantation
may
restore
responsiveness
ICI-resistant
melanoma.
Here,
we
review
yin
yang
bacteria
at
crossroads
between
barrier,
metabolism,
local
or
systemic
during
therapies.
We
discuss
diagnostic
tools
identify
gut
dysbiosis
future
prospects
microbiota-based
therapeutic
interventions.
SIGNIFICANCE:
Given
recent
proof
concept
potential
in
patients
with
melanoma
primarily
resistant
PD-1
blockade,
it
timely
how
why
antibiotics
compromise
cancer
immunotherapy,
describe
balance
beneficial
harmful
species
play
therapies,
introduce
for
microbiota-centered
interventions
immuno-oncology.
Aging,
Journal Year:
2021,
Volume and Issue:
13(5), P. 6375 - 6405
Published: March 2, 2021
teaching
and
research
institutions
in
France
or
abroad,
from
public
private
centers.L'archive
ouverte
pluridisciplinaire
HAL,
est
destinée
au
dépôt
et
à
la
diffusion
de
documents
scientifiques
niveau
recherche,
publiés
ou
non,
émanant
des
établissements
d'enseignement
recherche
français
étrangers,
laboratoires
publics
privés.
Signal Transduction and Targeted Therapy,
Journal Year:
2022,
Volume and Issue:
7(1)
Published: July 23, 2022
Nutriments
have
been
deemed
to
impact
all
physiopathologic
processes.
Recent
evidences
in
molecular
medicine
and
clinical
trials
demonstrated
that
adequate
nutrition
treatments
are
the
golden
criterion
for
extending
healthspan
delaying
ageing
various
species
such
as
yeast,
drosophila,
rodent,
primate
human.
It
emerges
develop
precision-nutrition
therapeutics
slow
age-related
biological
processes
treat
diverse
diseases.
However,
nutritive
advantages
frequently
diversify
among
individuals
well
organs
tissues,
which
brings
challenges
this
field.
In
review,
we
summarize
different
forms
of
dietary
interventions
extensively
prescribed
improvement
disease
treatment
pre-clinical
or
clinical.
We
discuss
nutrient-mediated
mechanisms
including
metabolic
regulators,
metabolism
pathways,
epigenetic
circadian
clocks.
Comparably,
describe
diet-responsive
effectors
by
influence
endocrinic,
immunological,
microbial
neural
states
responsible
improving
health
preventing
multiple
diseases
humans.
Furthermore,
expatiate
patterns
dietotheroapies,
fasting,
calorie-restricted
diet,
ketogenic
high-fibre
plants-based
protein
restriction
diet
with
specific
reduction
amino
acids
microelements,
potentially
affecting
morbid
states.
Altogether,
emphasize
profound
nutritional
therapy,
highlight
crosstalk
explored
critical
factors
individualized
therapeutic
approaches
predictors.
Frontiers in Oncology,
Journal Year:
2022,
Volume and Issue:
12
Published: Aug. 29, 2022
Tumor
acidity
is
one
of
the
cancer
hallmarks
and
associated
with
metabolic
reprogramming
use
glycolysis,
which
results
in
a
high
intracellular
lactic
acid
concentration.
Cancer
cells
avoid
stress
major
by
activation
expression
proton
lactate
transporters
exchangers
have
an
inverted
pH
gradient
(extracellular
pHs
are
alkaline,
respectively).
The
shift
tumor
acid-base
balance
promotes
proliferation,
apoptosis
avoidance,
invasiveness,
metastatic
potential,
aggressiveness,
immune
evasion,
treatment
resistance.
For
example,
weak-base
chemotherapeutic
agents
may
substantially
reduced
cellular
uptake
capacity
due
to
"ion
trapping".
Lactic
negatively
affects
functions
activated
effector
T
cells,
stimulates
regulatory
them
express
programmed
cell
death
receptor
1.
On
other
hand,
inversion
could
be
weakness
that
will
allow
development
new
promising
therapies,
such
as
tumor-targeted
pH-sensitive
antibodies
pH-responsible
nanoparticle
conjugates
anticancer
drugs.
regulation
levels
pharmacological
inhibition
proteins
(monocarboxylate
transporters,
H
Immunity,
Journal Year:
2022,
Volume and Issue:
55(2), P. 210 - 223
Published: Feb. 1, 2022
Nutrition
affects
all
physiological
processes
including
those
linked
to
the
development
and
function
of
our
immune
system.
Here,
we
discuss
recent
evidence
emerging
concepts
supporting
idea
that
newfound
relationship
with
nutrition
in
industrialized
countries
has
fundamentally
altered
way
which
system
is
wired.
This
will
be
examined
through
lens
studies
showing
mild
or
transient
reductions
dietary
intake
can
enhance
protective
immunity
while
also
limiting
aberrant
inflammatory
responses.
We
further
how
trade-offs
priorities
begin
emerge
context
severe
nutritional
stress.
In
settings,
specific
immunological
functions
are
heightened
re-enforce
tissue
sites
most
critical
survival.
Altogether,
these
examples
emphasize
profound
influence
over
highlight
a
mechanistic
exploration
this
cross
talk
could
ultimately
lead
design
novel
therapeutic
approaches
prevent
treat
disease.
Cancer Research,
Journal Year:
2022,
Volume and Issue:
82(8), P. 1575 - 1588
Published: March 21, 2022
The
dynamic
composition
of
the
tumor
microenvironment
(TME)
can
markedly
alter
response
to
targeted
therapies
for
colorectal
cancer.
Cancer-associated
fibroblasts
(CAF)
are
major
components
TMEs
that
direct
and
induce
infiltration
immunosuppressive
cells
through
secreted
cytokines
such
as
CXCL12.
Ketogenic
diets
(KD)
inhibit
growth
enhance
anticancer
effects
immune
checkpoint
blockade.
However,
role
ketogenesis
on
TME
is
not
known.
Here,
we
show
decreased
a
signature
cancer
an
increase
in
using
KD
decreases
CXCL12
production
tumors,
serum,
liver,
lungs.
Moreover,
increasing
by
overexpression
ketogenic
enzyme
3-hydroxy-3-methylglutaryl-CoA
synthase
2
(HMGCS2)
or
treatment
with
ketone
body
β-hydroxybutyrate
expression
KLF5,
which
binds
promoter
induces
CAFs.
intratumoral
accumulation
cells,
increased
natural
killer
cytotoxic
T
enhanced
PD-1
blockade
murine-derived
Furthermore,
inhibited
migration,
invasion,
metastasis
vitro
vivo.
Overall,
downregulated
TME,
represses
KLF5-dependent
improve
leads
efficacy
immunotherapy
reduced
metastasis.
Importantly,
this
work
demonstrates
downregulation
de
novo
critical
step
progression.This
study
identifies
regulator
suggests
potential
metabolic
strategy
overcome
immunosuppression
prolong
survival.
See
related
commentary
Montrose
Galluzzi,
p.
1464.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: March 11, 2024
Abstract
Diet,
serving
as
a
vital
source
of
nutrients,
exerts
profound
influence
on
human
health
and
disease
progression.
Recently,
dietary
interventions
have
emerged
promising
adjunctive
treatment
strategies
not
only
for
cancer
but
also
neurodegenerative
diseases,
autoimmune
cardiovascular
metabolic
disorders.
These
demonstrated
substantial
potential
in
modulating
metabolism,
trajectory,
therapeutic
responses.
Metabolic
reprogramming
is
hallmark
malignant
progression,
deeper
understanding
this
phenomenon
tumors
its
effects
immune
regulation
significant
challenge
that
impedes
eradication.
Dietary
intake,
key
environmental
factor,
can
tumor
metabolism.
Emerging
evidence
indicates
might
affect
the
nutrient
availability
tumors,
thereby
increasing
efficacy
treatments.
However,
intricate
interplay
between
pathogenesis
other
diseases
complex.
Despite
encouraging
results,
mechanisms
underlying
diet-based
remain
largely
unexplored,
often
resulting
underutilization
management.
In
review,
we
aim
to
illuminate
various
interventions,
including
calorie
restriction,
fasting-mimicking
diet,
ketogenic
protein
restriction
high-salt
high-fat
high-fiber
aforementioned
diseases.
We
explore
multifaceted
impacts
these
encompassing
their
immunomodulatory
effects,
biological
impacts,
molecular
mechanisms.
This
review
offers
valuable
insights
into
application
therapies